RFCA
PRAH

R&F Capital Advisors’s PRA Health Sciences, Inc. PRAH Stock Holding History

R&F Capital Advisors’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$630K Buy
+9,658
New +$569K 0.16% 192

Other funds holding PRAH

KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

R&F Capital Advisors's PRAH Position: Q1 2017 in Review

R&F Capital Advisors opened a new position in PRA Health Sciences, Inc. (PRAH) in Q1 2017: 9,658 shares worth $630K. The stake represents 0.16% of the portfolio and ranks #192 among its holdings.

229 funds tracked by Wall St. Rank hold PRAH as of Q1 2017.

  • R&F Capital Advisors held 9,658 shares of PRA Health Sciences, Inc. worth $630K as of Q1 2017.
  • PRA Health Sciences, Inc. was a new R&F Capital Advisors position in Q1 2017.
  • PRA Health Sciences, Inc. made up 0.16% of R&F Capital Advisors's portfolio in Q1 2017, its #192 holding.
  • 229 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2017.

Based on R&F Capital Advisors's 13F filing for Q1 2017, filed 15 May 2017.